TNGX
Tango Therapeutics Inc
NASDAQ: TNGX · HEALTHCARE · BIOTECHNOLOGY
$20.98
-2.96% today
Updated 2026-05-01
Market cap
$3.18B
P/E ratio
—
P/S ratio
51.01x
EPS (TTM)
$-0.87
Dividend yield
—
52W range
$1 – $28
Volume
3.5M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+5.0
Quality
C+2.0
Profitability
F6.0
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$23.90
+13.92%
12-Month target
—
—
Intrinsic (DCF)
$16.11
Margin of safety
+21.73%
1 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 21.73% below intrinsic value
Risks
- Thin margins at -162.90%
- Negative free cash flow $-29.94M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $24.86M | $36.53M | $42.07M | $62.38M | $62.38M |
| Net income | $-108.18M | $-101.74M | $-130.30M | $-101.59M | $-38.75M |
| EPS | — | — | — | — | $-0.87 |
| Free cash flow | $-116.77M | $-119.51M | $-132.25M | $-139.93M | $-29.94M |
| Profit margin | -435.14% | -278.54% | -309.73% | -162.85% | -162.90% |
Peer comparison
Smart narrative
Tango Therapeutics Inc trades at $20.98. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $62.38M. with profit margins at -162.90%. Our DCF model estimates intrinsic value at $16.11.
Frequently asked questions
What is Tango Therapeutics Inc's stock price?
Tango Therapeutics Inc (TNGX) trades at $20.98.
Is Tango Therapeutics Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $16.11.
What is the price target of Tango Therapeutics Inc (TNGX)?
The analyst target price is $23.90, representing +13.9% upside from the current price of $20.98.
What is the intrinsic value of Tango Therapeutics Inc (TNGX)?
Based on our DCF model, intrinsic value is $16.11, a +21.7% margin of safety versus $20.98.
What is Tango Therapeutics Inc's revenue?
TTM revenue is $62.38M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio51.01x
ROE-37.20%
Beta1.32
50D MA$19.13
200D MA$11.27
Shares out0.14B
Float0.07B
Short ratio—
Avg volume3.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—